SCHEMBL870550

SCHEMBL870550

CCC=C(O)CCCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 7/20 0.48
PPARD Q03181 7/20 0.48
PPARA Q07869 7/20 0.48
HDAC11 Q96DB2 5/20 0.48
TSHR P16473 4/20 0.48
PTPN1 P18031 3/20 0.48
FABP4 P15090 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALOX15 P16050 2/20 0.48
HSD17B10 Q99714 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48
PDE4A P27815 1/20 0.48
KMT2A Q03164 1/20 0.48
PDE3A Q14432 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11850685 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11849168 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11849165 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL9997344 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL11850680 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL25425408 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3363214 1.00 GPR84 (0.48) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL28518096 0.98 GPR84 (0.46) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3361822 0.97 AKR1B1 (0.46) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL3361824 0.97 AKR1B1 (0.46) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448869-A Preparation method of intermediate for synthesizing spirotetramat 顺毅南通化工有限公司 2022-12-09 CN claimed
CN-115466208-B Method for purifying spirotetramat cis-intermediate 安徽宁亿泰科技有限公司 2024-05-14 CN disclosed
CN-115466208-B Method for purifying spirotetramat cis-intermediate 安徽宁亿泰科技有限公司 2024-05-14 CN disclosed
CN-112745286-B Preparation method of spirodiclofen diester derivative 浙江宇龙药业有限公司 2023-01-24 CN disclosed
CN-115466208-A Method for purifying cis-intermediate of spirotetramat 安徽宁亿泰科技有限公司 2022-12-13 CN disclosed
CN-115466208-A Method for purifying cis-intermediate of spirotetramat 安徽宁亿泰科技有限公司 2022-12-13 CN disclosed
CN-115448869-A Preparation method of intermediate for synthesizing spirotetramat 顺毅南通化工有限公司 2022-12-09 CN disclosed
CN-115448869-A Preparation method of intermediate for synthesizing spirotetramat 顺毅南通化工有限公司 2022-12-09 CN disclosed
US-10590299-B2 Paint, adhesive composition, bonding method and laminate RIKEN TECHNOS CORP. (JP) 2020-03-17 US disclosed
WO-2019228788-A1 2-BROMO-6-ALKOXYPHENYL-SUBSTITUTED PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2019-12-05 WO disclosed
US-7709598-B2 Fluorinated alkyl fluorophoshoric acid salts of onium and transition metal complex SAN-APRO LIMITED (JP) 2010-05-04 US disclosed
WO-2010043311-A1 METHOD FOR PRODUCING SPIROCYCLIC TETRONIC ACID DERIVATIVES BREITSCHUH RICHARD (CN) 2010-04-22 WO disclosed
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex SAN-APRO LIMITED (JP) 2007-09-27 US disclosed
EP-1752463-A1 NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX San-Apro Limited (JP) 2007-02-14 EP disclosed
EP-0815149-A1 AQUEOUS SOLUTIONS OR DISPERSIONS OF COPOLYMERS OF MONOETHYLENICALLY UNSATURATED DICARBOXYLIC ACIDS OR THEIR ANHYDRIDES AND OF BRANCHED CHAIN OLIGOMERS OR POLYMERS BASF AKTIENGESELLSCHAFT (DE) 1998-01-07 EP disclosed
WO-1996028483-A1 AQUEOUS SOLUTIONS OR DISPERSIONS OF COPOLYMERS OF MONOETHYLENICALLY UNSATURATED DICARBOXYLIC ACIDS OR THEIR ANHYDRIDES AND OF BRANCHED CHAIN OLIGOMERS OR POLYMERS BASF AKTIENGESELLSCHAFT (DE) 1996-09-19 WO disclosed
US-5106705-A Vinyl ether siloxanes as protective coatings and soil-release surfacings ISP INVESTMENTS INC. (US) 1992-04-21 US disclosed
US-5026810-A Vinyl ether siloxanes GAF CHEMICALS CORPORATION (US) 1991-06-25 US disclosed
US-4368292-A ACRYLIC ESTER, VINYL ESTER; TOUGHNESS, FLEXIBILITY BAYER AKTIENGESELLSCHAFT (DE) 1983-01-11 US disclosed
US-3984478-A TREATING AN UNSATURATED COMPOUND WITH CARBON MONOXIDE IN A HETEROGENEOUS CATALYST UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225458-A1 Novel Fluorinated Alkyl Fluorophosphoric Acid Salts of Onium and Ttransition Metal Complex AS3MT, TTR, PFAS GPR84 4381/4885PPARG 2723/4885PPARD 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.